June 26, 2026
Lycia Therapeutics
Lycia Therapeutics is a biotech company targeting disease-causing extracellular proteins.
- Round
- Series D
- Amount raised
- $75M
- Lead investor
- Balyasny Asset Management
- Industry
- —
- Headquarters
- —
- Employees
- 11-50 employees
- Website
- —
- View profile →
Other investors
- Adage Capital Management
- HBM Healthcare Investments
- OrbiMed
- Eli Lilly
- Franklin Templeton
- Invus
- RTW Investments
- Venrock Healthcare Capital Partners
Source: Axios Pro Rata